[Lung injury]

Nihon Rinsho. 2012 Aug:70 Suppl 6:159-65.

[Article in Japanese]

Authors

Yoshinobu Saito¹, Akihiko Gemma

Affiliation

¹ Division of Pulmonary Medicine, Infectious Diseases, and Oncology, Department of Internal Medicine, Nippon Medical School.

PMID: 23156502

No abstract available

MeSH terms

Antineoplastic Agents / adverse effects*
Erlotinib Hydrochloride
Everolimus
Gefitinib
Humans
Lung Diseases / chemically induced*
Lung Diseases / diagnosis
Lung Diseases / therapy
Quinazolines / adverse effects
Sirolimus / adverse effects
Sirolimus / analogs & derivatives

Substances

Antineoplastic Agents
Quinazolines
temsirolimus
Everolimus
Erlotinib Hydrochloride
Gefitinib
Sirolimus